| Literature DB >> 18330989 |
Patrick Schneider1, Mathias Misiek, Dirk Hoffmeister.
Abstract
Microbial natural products, among them a vast diversity of fungal origin, represent a major source for new drug candidates. Focusing on fungal metabolites, our review covers recent advances in the field of biotransformation, heterologous expression, in vivo production approaches, genomics, and the metabolism of unexplored fungal groups as options to generate and identify new compounds or optimize known ones.Mesh:
Substances:
Year: 2008 PMID: 18330989 DOI: 10.1021/mp7001544
Source DB: PubMed Journal: Mol Pharm ISSN: 1543-8384 Impact factor: 4.939